After matching the patients for age, BMI, diabetes, insulin, and continuous positive airway pressure (CPAP) treatment, there were no significant differences in outcome regarding weight loss and improvement of obesity-related comorbidities [131]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.